Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial

External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus

(2017) Jennifer E. Brandt et al.   ARTHRITIS CARE & RESEARCH

Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus

(2017) Stephanie G. Nantes et al.   ARTHRITIS CARE & RESEARCH

The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index

(2016) H Devilliers et al.   LUPUS

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus

(2016) Kathleen McElhone et al.   ARTHRITIS CARE & RESEARCH

Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus

(2016) Meenakshi Jolly et al.   Arthritis & Rheumatology

Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus

(2015) D Giangreco et al.   LUPUS

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus

(2015) Sharan K Rai et al.   ARTHRITIS RESEARCH & THERAPY

Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE

(2014) H. Devilliers et al.   RHEUMATOLOGY

The BILAG-2004 systems tally—a novel way of representing the BILAG-2004 index scores longitudinally

(2012) Chee-Seng Yee et al.   RHEUMATOLOGY

Disease-Specific Patient Reported Outcome Tools for Systemic Lupus Erythematosus

(2012) Meenakshi Jolly et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale in Patients with Moderately to Severely Active Systemic Lupus Erythematosus, Participating in a Clinical Trial

(2011) J.-S. LAI et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM

Psychometric Properties of the EuroQol-5D and Short Form-6D in Patients with Systemic Lupus Erythematosus

(2009) R. AGGARWAL et al.   JOURNAL OF RHEUMATOLOGY